Navigation Links
FDAnews announces Fifth Annual Risk Management & Drug Safety Summit
Date:11/9/2012

FALLS CHURCH, Va., Nov. 9, 2012 /PRNewswire-iReach/ --
Fifth Annual Risk Management & Drug Safety Summit:
Building an Effective Global Risk Management and Drug Safety Program
**Presented by FDAnews**
Dec. 3-4, 2012 – Washington, DC

(Photo: http://photos.prnewswire.com/prnh/20121109/CG10179)

www.fdanews.com/REMS

There are now about 200 unique REMS and four classwide REMS.  And big changes are coming.

PDUFA V moves REMS discussions earlier in the review process for sponsors of new molecular entity NDAs and original BLAs. With REMS discussions commencing as early as pre-NDA meetings, the agency is determining how to create a more predictable system for requiring REMS and deciding what tools a REMS should involve.

CDER (in conjunction with CBER) plans to issue new guidance to determine when a REMS is required, both preapproval and postapproval. The guidance must be released in September 2013.

Plus, the FDA is planning to hold a series of public meetings to determine the best methods for assessing the effectiveness of REMS.

Are you in the know on these changes?  Will you be ready when they hit your product?

Register today to join a select group of drug industry executives who have, over the past four years, sought to shape the future of REMS and global drug safety.

This is your year to be among them.  Register now to join with colleagues for the Fifth Annual Risk Management and Drug Safety Summit.

Invest two days. Meet new colleagues and make new contacts. Ask questions directly of industry thoughts leaders, such as Douglas Throckmorton, M.D., Deputy Director Regulatory Programs, CDER, FDA (invited), Greg Fiore, M.D., Chief Medical Officer and Acting Head of Global Pharmacovigilance, The Medicines Company and Ri
'/>"/>

SOURCE FDAnews
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDAnews announces Third Annual Pharmaceutical Labeling Summit
2. FDAnews Announces Medical Device Mobile Apps Virtual Conference
3. FDAnews announces Fourth Annual Supplier Quality Congress
4. Telik Announces Third Quarter 2012 Financial Results
5. Cannabis Science Provides Corporate Guidance on Preclinical Initiatives and Recent Corporate Developments for its Shareholders; CBIS Announces plans for 1st Q of 2013 Webinar Investor Call
6. Array BioPharma Announces Pricing Of Public Offering Of Common Stock
7. IntelliCell BioSciences Announces FDA Registration for its Cell Processing Facility
8. NxStage Announces Fourth Quarter 2012 Investor Conference Schedule
9. Unilife Corporation Announces Financial Results For Fiscal Year 2013 First Quarter
10. Array BioPharma Announces Proposed Public Offering Of Common Stock
11. Allscripts Announces Third Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
(Date:1/15/2014)... 2014  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ... System as a non-invasive, wireless continuous glucose monitoring system, ... Chairman and Interim CEO of Echo Therapeutics, will present ... Conference. Mr. Doman will make a ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com ... is available in its catalogue: ... Drug Forecast and Market Analysis to 2022 ... PharmaPoint: Atopic Dermatitis - India Drug Forecast ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... Inc.,(Nasdaq: MEDX ) today announced interim ... an investigational oncology immunotherapy, as monotherapy or ... castration,resistant prostate cancer (mCRPC). Data presented showed ... was clinically active and,generally well-tolerated. Preliminary evidence ...
... and REGENSBURG, Germany, June 2 "A ... in recurrent or refractory anaplastic,astrocytoma suggests a ... commented Prof. Ulrich Bogdahn, Neuro-Oncologist and Coordinating,Investigator ... with AP,12009 in recurrent or refractory high-grade ...
Cached Medicine Technology:Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting 2Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting 3Interim Phase 1/2 Data of Ipilimumab in Prostate Cancer Presented at American Society of Clinical Oncology Annual Meeting 4Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 2Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 3Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 4
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
(Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
(Date:4/17/2014)... has the potential to ward off depression among retirees, ... published online in The Journals of Gerontology, ... In the article " Internet Use and Depression Among ... Analysis ," the authors report that Internet use reduced ... among their study sample. , Late-life depression affects ...
(Date:4/17/2014)... days to find a colored ribbon representing a disease. A ... what color ribbon does one think of with lung cancer?, ... many suffering from the disease, black may be the only ... of lung cancer patients, primarily smokers between the ages of ... the stigma often felt by these patients, the emotional toll ...
(Date:4/17/2014)... world is less than 40 years away from a ... and governments, according to a top scientist at the ... in human history, food production will be limited on ... and energy," said Dr. Fred Davies, senior science advisor ... could become as politically destabilizing by 2050 as energy ...
Breaking Medicine News(10 mins):Health News:Is Parkinson's an autoimmune disease? 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Internet use may cut retirees' depression 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Food shortages could be most critical world issue by mid-century 2
... over age 65, experts note, , THURSDAY, May 13 ... heartbeat known as atrial fibrillation in a certain way, ... forms of dementia, new research finds. , In atrial ... causing blood to pool and increasing the potential of ...
... who need more supplementation, study suggests , THURSDAY, May ... in the United States don,t get enough vitamin D, ... prenatal vitamins that many women take do not always ... researchers from the University of Colorado Denver School of ...
... ... research studies of the jellyfish protein apoaequorin accessible for individuals with debilitating conditions. People ... the research arm of Quincy Bioscience. , ... Madison, WI (Vocus) May 13, 2010 -- Quincy Bioscience announces the launch of ...
... ... RQi enterprise™ registration quality improvement solution allows for pre-registration information to be QA managed ... ... Technologies is proud to announce that Piedmont Healthcare Inc. has selected RQi enterprise™ ( ...
... ... Hearing Loss and Hearing Aids ( http://www.aidright.com ) , ... (PRWEB) May 13, 2010 -- AidRight audiology professionals ... caregiver. Through extensive informational portals and a trusted provider network, their newly relaunched ...
... senior citizen,s health, yet fewer than half of all seniors see ... attention are far less likely to engage in any of the ... medications or getting a cane or walker that might prevent ... Center for Health Policy Research. In the study, ...
Cached Medicine News:Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 2Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 3Health News:Many Pregnant Woman Not Getting Enough Vitamin D 2Health News:Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants 2Health News:Kramer Healthcare Technologies' RQi enterprise™ Revenue Cycle Solution Selected by Piedmont Healthcare 2Health News:Caregivers Find Hearing Loss Newly Relaunched Website a Welcome Help 2Health News:Falls and follow-ups: Medical attention following a fall critical to senior health 2
... MRAnywhere stands for Medical Records ... Medical Records (EMR) software that ... from within your office, hospital, ... Web. MRAnywhere offers conversion from ...
SOAPware is an Electronic Health Record for clinics. We provide tools to link to billing systems, hospitals, labs, etc....
... Medical Record Software Interface ... Interface with programs, populates ... custom reports. Accumedics Electronic ... is Microsoft compatible allowing ...
... VersaSuite EHR is designed to improve the ... offers the clinician the ability to capture ... in text, image, audio or video formats. ... provides a familiar contemporary windows interface and ...
Medicine Products: